| A Novel Anti-HER2 Bispecific Antibody With Potent Tumor Inhibitory Effects In Vitro and In Vivo M Mohammadi, M Jeddi-Tehrani, F Golsaz-Shirazi, M Arjmand, ... Frontiers in Immunology 11, 600883, 2021 | 16 | 2021 |
| Hersintuzumab: A novel humanized anti-HER2 monoclonal antibody induces potent tumor growth inhibition MM Amiri, F Golsaz-Shirazi, T Soltantoyeh, R Hosseini-Ghatar, ... Investigational new drugs 36, 171-186, 2018 | 10 | 2018 |
| Diagnostic performance of a novel antigen-capture ELISA for the detection of SARS-CoV-2 H Yadegari, M Mohammadi, F Maghsood, A Ghorbani, T Bahadori, ... Analytical Biochemistry 666, 115079, 2023 | 8 | 2023 |
| Differential effects of inhibitory and stimulatory anti-HER2 monoclonal antibodies on AKT/ERK signaling pathways T Soltantoyeh, T Bahadori, R Hosseini-Ghatar, J Khoshnoodi, A Roohi, ... Asian Pacific journal of cancer prevention: APJCP 19 (8), 2255, 2018 | 6 | 2018 |
| Epitope mapping of human HER2 specific mouse monoclonal antibodies using recombinant extracellular subdomains RH Ghatar, T Soltantoyeh, T Bahadori, M Golara, H Hassannia, ... Asian Pacific journal of cancer prevention: APJCP 18 (11), 3103, 2017 | 6 | 2017 |
| Potent synergistic anti-tumor activity of a novel humanized anti-HER2 antibody hersintuzumab in combination with trastuzumab in xenograft models F Shiravi, M Mohammadi, F Golsaz-Shirazi, T Bahadori, MA Judaki, ... Investigational New Drugs 39, 697-704, 2021 | 5 | 2021 |
| Generation and Characterization of Novel Diagnostic Mouse Monoclonal Antibodies Against Human Estrogen Receptor Alpha and Progesterone Receptor MH Makoui, M Mobini, J Khoshnoodi, MA Judaki, T Bahadori, HA Zare, ... Asian Pacific Journal of Cancer Prevention: APJCP 23 (9), 2999, 2022 | 3 | 2022 |
| Characterization of Monoclonal and Polyclonal Antibodies Recognizing Prostate Specific Antigen: Implication for Design of a Sandwich ELISA SR Mohseni, F Golsaz-Shirazi, M Hosseini, J Khoshnoodi, T Bahadori, ... Avicenna Journal of Medical Biotechnology 11 (1), 72, 2019 | 3 | 2019 |
| Novel mouse monoclonal antibodies against Bordetella pertussis pertactin antigen with versatile applications D Imani, T Bahadori, S Ghourchian, F Golsaz-Shirazi, M Douraghi, ... Journal of Microbiological Methods 211, 106786, 2023 | 2 | 2023 |
| Potent anti-tumor immune response and tumor growth inhibition induced by HER2 subdomain fusion protein in a mouse tumor model M Ghaedi, F Golsaz-Shirazi, T Bahadori, J Khoshnoodi, S Mortezagholi, ... Journal of Cancer Research and Clinical Oncology 149 (6), 2437-2450, 2023 | 2 | 2023 |
| Inhibitory effect of polyclonal antibodies against HER3 extracellular subdomains on breast cancer cell lines S Mansouri-Fard, M Ghaedi, MR Shokri, T Bahadori, J Khoshnoodi, ... Asian Pacific journal of cancer prevention: APJCP 21 (2), 439, 2020 | 2 | 2020 |
| Development of a novel inhibitory chimeric anti-HER2 monoclonal antibody MM Amiri, T Bahadori, T Soltantoyeh, R Hosseini-Ghatar, ... Iranian Journal of Immunology 16 (1), 26-42, 2019 | 2 | 2019 |
| High purity and recovery of native filamentous hemagglutinin (FHA) from Bordetella pertussis using affinity chromatography D Imani, T Bahadori, F Golsaz-Shirazi, M Douraghi, M Jeddi-Tehrani, ... Journal of Chromatography B 1239, 124122, 2024 | | 2024 |
| Comparison of different transient gene expression systems for the production of a new humanized anti-HER2 monoclonal antibody (Hersintuzumab) A Roshani, M Mohammadi, T Bahadori, H Ahmadi Zare, MA Judaki, ... DARU Journal of Pharmaceutical Sciences 31 (2), 221-231, 2023 | | 2023 |
| Novel neutralizing mouse-human chimeric monoclonal antibodies against the SARS-CoV-2 receptor binding domain A Ghorbani, F Maghsood, H Yadegari, T Bahadori, AH Zarnani, ... Journal of Medical Microbiology 72 (6), 001728, 2023 | | 2023 |
| Novel Monoclonal Antibodies Specific for Human Ki67 and P53 Tumor Markers in Breast Cancer Tissue Samples M Hassanzadeh Makoui, M Mobini, J Khoshnoodi, T Bahadori, ... Iranian Journal of Immunology 20 (2), 177-189, 2023 | | 2023 |
| Novel Monoclonal Antibodies Specific for Human Ki67 and P53 Tumor Markers in Breast Cancer Tissue Samples. M Mobini, J Khoshnoodi, T Bahadori, F Golsaz-Shirazi, Z Madjd, ... Iranian Journal of Immunology: IJI 20 (2), 2023 | | 2023 |
| A Novel Fc-Engineered Anti-HER2 Bispecific Antibody With Enhanced Antitumor Activity M Mohammadi, M Jeddi-Tehrani, F Golsaz-Shirazi, M Arjmand, ... Journal of Immunotherapy 46 (4), 121-131, 2023 | | 2023 |
